BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo. The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic. Richard Hatchett, head of CEPI, told Reuters it was possible to get vaccines against Ebola Bundibugyo ready for trials within a couple of months.

Director-General Jean Kaseya told a virtual press conference that Africa CDC's partners on Monday had pledged almost $500 million to support the fight against the outbreak.

Coalition for Epidemic Preparedness Innovationsfunding builds on Moderna's prior filovirus research and supports preclinical development and Phase 1 clinical evaluation CAMBRIDGE,…

This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has seen over 900 suspected cases and more than 220…

L’ente globale per la salute CEPI sta accelerando lo sviluppo di vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola. Il focolaio in Africa centrale continua a propagarsi

Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

L’ente globale per la salute CEPI sta accelerando lo sviluppo di tre vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola, mentre il focolaio in Africa centrale continua a…

CEPI is committing up to $50 million to support Moderna's vaccine candidate for the strain with no approved shot

Four nurses discharged from DR Congo hospital after recovering from virus

Coaliția pentru Inovații în domeniul Pregătirii pentru Epidemii (CEPI) va „accelera de urgență” dezvoltarea a trei vaccinuri experimentale împotriva virusului Bundibugyo,…

Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebo...

Parceria entre Moderna e CEPI foca em vacina contra a cepa Bundibugyo do ebola, enquanto a OMS prioriza imunizantes experimentais para conter surto no Congo.

Doença já registrou cerca de 900 casos suspeitos e mais de 220 mortes suspeitas

Der US-Pharmakonzern will mit Unterstützung der internationalen Impfallianz CEPI einen Impfstoff gegen das Bundibugyo-Ebolavirus herstellen. Diese Ebola-Variante verbreitet sich…

While it marks the 17th Ebola outbreak in the DRC, it is just the third caused by the Bundibugyo strain, for which there are no...

Alors que l’épidémie d’Ebola Bundibugyo continue de progresser en République démocratique du Congo et en Ouganda, plusieurs organisations internationales débloquent des dizaines…

BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…

A global body set up to accelerate the development of vaccines has pledged $62 million to speed up progress on experimental jabs aimed at tackling the virus behind the Ebola…

Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.

With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.

Gavi will allocate up to $50 million to combat the Bundibugyo ebola outbreak, focusing on vaccine development and outbreak response efforts. | India News